Shenyi X. Yin
State Key Laboratory Of Natural And Biomimetic Drugs, Beijing Key Laboratory Of Tumor Organoid And Digital Tumor Twin
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: June 05, 2026
Cholesteryl ester accumulation as a biomarker for personalized selection of fertility-preserving therapies in endometrioid endometrial carcinoma.
Journal: Science bulletin
Published: February 12, 2026
Matrigel/serum-free, high-fidelity patient-derived tumor-like cell clusters as an in vitro platform for large-scale compound screening and chemoresistance prediction in oral cancer.
Journal: BMC medicine
Published: January 29, 2026
Predictive Value of Patient-Derived Tumor Cell Cluster-Based Drug Sensitivity Assay in Advanced NSCLC.
Journal: Clinical Medicine Insights. Oncology
Published: August 09, 2025
Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Patients with Stage II-III Colorectal Cancer.
Journal: Annals of surgical oncology
Published: July 02, 2025
Intratumoural vaccination via checkpoint degradation-coupled antigen presentation.
Journal: Nature
Published: December 15, 2024
Personalizing colorectal Cancer treatment: Chemotherapy drug testing with patient-derived tumor cell clusters.
Journal: Translational oncology
Published: September 22, 2024
Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas.
Journal: Cell reports. Medicine
Published: June 30, 2024
Last Updated: 09/26/2026